Literature DB >> 23457048

Mixing tests: diagnostic aides in the investigation of prolonged prothrombin times and activated partial thromboplastin times.

Geoffrey Kershaw1, Daniel Orellana.   

Abstract

Mixing tests are a relatively simple procedure used in the hemostasis laboratory as a first-line investigation into the cause of an abnormal screening test, typically a prolonged activated partial thromboplastin time and/or a prolonged prothrombin time. The mixing test involves combining the test plasma with normal plasma, then repeating the screening test on the mixture to assess whether the clotting time becomes normal or remains prolonged. The primary purpose of a mixing test is to guide further investigations. When mixing test results "normalize," this suggests the test plasma is deficient in clotting factor(s) and thus specific factor assays can be performed to determine which are reduced. When the mixing test result does not "normalize," this suggests the presence of an inhibitor or other type of interference (e.g., the presence of an anticoagulant such as high-dose heparinoids), and so the laboratory needs to determine if this is a lupus anticoagulant or a specific coagulation factor inhibitor, or another type of inhibitor. Because these follow-up investigations are more costly and time-consuming than the basic screening tests, the appropriate performance and interpretation of mixing tests is advantageous for the laboratory. Moreover, the correct laboratory approach is also clinically relevant, as patient management is ultimately affected, and an incorrect interpretation may lead to inappropriate therapies being established. Components of a mixing test that can influence result interpretation include the sensitivity of the used screening reagents to various factor deficiencies and inhibitors, the source or composition of the normal plasma, and the setting of cutoffs for the formula used in expressing mixing test results. Numerous and differing criteria for mixing test interpretation have been suggested historically, which can lead to confusion as to which approach is the most appropriate. The use of differing criteria will also lead to differing interpretations regarding "normalization." For this pivotal reason, standardized mixing test procedures and a consistent set of validated interpretive criteria represent the most favorable approach to maximizing the utility of a mixing test, and ensure the most accurate diagnosis for investigated patients. Thieme Medical Publishers 333 Seventh Avenue, New York, NY 10001, USA.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23457048     DOI: 10.1055/s-0033-1336832

Source DB:  PubMed          Journal:  Semin Thromb Hemost        ISSN: 0094-6176            Impact factor:   4.180


  8 in total

1.  What should be the laboratory approach against isolated prolongation of a activated partial thromboplastin time?

Authors:  Mesude Falay; Mehmet Senes; Dogan Yücel; Turan Turhan; Simten Dagdaş; Melike Pekin; Namik K Nazaroglu; Gülsüm Özet
Journal:  J Clin Lab Anal       Date:  2018-02-27       Impact factor: 2.352

2.  Acquired haemophilia A: Italian Consensus Recommendations on diagnosis, general management and treatment of bleeding.

Authors:  Antonio Coppola; Massimo Franchini; Armando Tripodi; Rita C Santoro; Giancarlo Castaman; Renato Marino; Ezio Zanon; Cristina Santoro; Gianna F Rivolta; Laura Contino; Raimondo De Cristofaro; Angelo C Molinari; Paolo Gresele; Angiola Rocino
Journal:  Blood Transfus       Date:  2022-01-20       Impact factor: 5.752

3.  Troubleshooting an isolate prolongation of activated partial thromboplastin time in a patient with acute myocardial infarction-a paradigmatic case report.

Authors:  Giovanni Poli; Piero Castiglioni; Martina Montagnana; Emmanuel J Favaloro; Giuseppe Lippi
Journal:  Ann Transl Med       Date:  2016-11

4.  Prevalent factor XII deficiency in cancer patients with isolated aPTT prolongation.

Authors:  Dong-Yeop Shin; Hyo-Rak Lee; Hye Jin Kang; Im Il Na; Yoon Hwan Chang; Sung Hyun Yang
Journal:  Blood Res       Date:  2015-06-25

5.  Diagnosis and Management of Acquired Hemophilia A: Case Reports and a Literature Review.

Authors:  Ikhwan Rinaldi; Findy Prasetyawaty; Siti Fazlines; Kevin Winston; Yusuf Aji Samudera Nurrobi; Jessica Leoni; Ilham Hidayat Restu Tulus Maha; Satrio Wicaksono; Abdillah Yasir Wicaksono; Averina Octaxena Aslani; Rizkania Ikhsani
Journal:  Case Rep Med       Date:  2021-09-14

6.  The Prevalence of Coagulopathy and Associated Factors Among Adult Type II Diabetes Mellitus Patients Attending the University of Gondar Comprehensive Specialized Hospital, Northwest Ethiopia.

Authors:  Fasil Getu; Melak Aynalem; Segenet Bizuneh; Bamlaku Enawgaw
Journal:  Diabetes Metab Syndr Obes       Date:  2022-02-24       Impact factor: 3.168

7.  Magnitude of Coagulation Abnormalities and Associated Factors Among Patients with Heart Diseases at the University of Gondar Comprehensive Specialized Hospital.

Authors:  Melak Aynalem; Tiruneh Adane; Solomon Getawa
Journal:  Vasc Health Risk Manag       Date:  2022-08-05

8.  Coagulopathy and its associated factors among patients with a bleeding diathesis at the University of Gondar Specialized Referral Hospital, Northwest Ethiopia.

Authors:  Melak Aynalem; Elias Shiferaw; Yemataw Gelaw; Bamlaku Enawgaw
Journal:  Thromb J       Date:  2021-06-01
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.